Chiara Brullo

3.9k total citations
114 papers, 3.2k citations indexed

About

Chiara Brullo is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Chiara Brullo has authored 114 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Molecular Biology, 63 papers in Organic Chemistry and 19 papers in Oncology. Recurrent topics in Chiara Brullo's work include Synthesis and biological activity (33 papers), Phosphodiesterase function and regulation (17 papers) and Cholinesterase and Neurodegenerative Diseases (14 papers). Chiara Brullo is often cited by papers focused on Synthesis and biological activity (33 papers), Phosphodiesterase function and regulation (17 papers) and Cholinesterase and Neurodegenerative Diseases (14 papers). Chiara Brullo collaborates with scholars based in Italy, United States and Switzerland. Chiara Brullo's co-authors include Silvia Schenone, Francesca Musumeci, Olga Bruno, Maurizio Botta, Marco Radi, Francesco Bondavalli, Angelo Ranise, Andrea Spallarossa, Bruno Tasso and Giovanni Maga and has published in prestigious journals such as Chemical Reviews, Biochemistry and Scientific Reports.

In The Last Decade

Chiara Brullo

110 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chiara Brullo Italy 33 1.8k 1.4k 388 372 261 114 3.2k
Daniela M. Zisterer Ireland 30 1.3k 0.7× 1.3k 0.9× 151 0.4× 308 0.8× 130 0.5× 114 2.5k
Joseph M. Salvino United States 34 1.2k 0.7× 2.3k 1.6× 208 0.5× 691 1.9× 153 0.6× 106 3.7k
Chuan Shih United States 32 790 0.5× 1.4k 1.0× 270 0.7× 687 1.8× 129 0.5× 81 2.9k
Maryse Leost France 17 1.3k 0.8× 2.0k 1.4× 305 0.8× 688 1.8× 50 0.2× 20 3.3k
Akira Asai Japan 33 938 0.5× 1.8k 1.2× 236 0.6× 649 1.7× 56 0.2× 132 3.0k
Armando Rossello Italy 33 895 0.5× 1.6k 1.1× 313 0.8× 1.0k 2.7× 117 0.4× 164 3.1k
Hiroyuki Miyachi Japan 28 665 0.4× 1.1k 0.8× 238 0.6× 340 0.9× 221 0.8× 93 2.1k
Gyoonhee Han South Korea 30 886 0.5× 1.5k 1.0× 236 0.6× 474 1.3× 72 0.3× 123 2.8k
Thelma S. Angeles United States 29 633 0.4× 1.5k 1.0× 100 0.3× 616 1.7× 185 0.7× 75 2.6k
Daniel L. Flynn United States 30 1.3k 0.7× 1.2k 0.8× 137 0.4× 245 0.7× 205 0.8× 100 2.4k

Countries citing papers authored by Chiara Brullo

Since Specialization
Citations

This map shows the geographic impact of Chiara Brullo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiara Brullo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiara Brullo more than expected).

Fields of papers citing papers by Chiara Brullo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chiara Brullo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiara Brullo. The network helps show where Chiara Brullo may publish in the future.

Co-authorship network of co-authors of Chiara Brullo

This figure shows the co-authorship network connecting the top 25 collaborators of Chiara Brullo. A scholar is included among the top collaborators of Chiara Brullo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chiara Brullo. Chiara Brullo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Musumeci, Francesca, Beatrice Casini, Chiara Brullo, et al.. (2025). Alzheimer’s Disease Etiology Hypotheses and Therapeutic Strategies: A Perspective. International Journal of Molecular Sciences. 26(14). 6980–6980. 2 indexed citations
2.
Spallarossa, Andrea, et al.. (2025). USP7 at the Crossroads of Ubiquitin Signaling, Cell Cycle, and Tumorigenesis. Molecules. 30(20). 4038–4038.
3.
Schepers, Melissa, Sven Hendrix, Peter Ponsaerts, et al.. (2024). Amelioration of functional and histopathological consequences after spinal cord injury through phosphodiesterase 4D (PDE4D) inhibition. Neurotherapeutics. 21(4). e00372–e00372. 5 indexed citations
4.
Spallarossa, Andrea, Eleonora Russo, Debora Caviglia, et al.. (2024). Investigations of Antioxidant and Anti-Cancer Activities of 5-Aminopyrazole Derivatives. Molecules. 29(10). 2298–2298. 1 indexed citations
5.
Spallarossa, Andrea, et al.. (2024). PDE4D: A Multipurpose Pharmacological Target. International Journal of Molecular Sciences. 25(15). 8052–8052. 11 indexed citations
6.
Brullo, Chiara, Francesca Musumeci, Enrico Millo, et al.. (2024). Recent Advances in the Discovery of SIRT1/2 Inhibitors via Computational Methods: A Perspective. Pharmaceuticals. 17(5). 601–601. 4 indexed citations
7.
Espinoza, Stefano, et al.. (2024). Computational Methods for the Discovery and Optimization of TAAR1 and TAAR5 Ligands. International Journal of Molecular Sciences. 25(15). 8226–8226.
8.
Bachetti, Tiziana, Andrea Spallarossa, Chiara Brullo, et al.. (2024). A Proteomics Approach Identifies RREB1 as a Crucial Molecular Target of Imidazo–Pyrazole Treatment in SKMEL-28 Melanoma Cells. International Journal of Molecular Sciences. 25(12). 6760–6760. 3 indexed citations
9.
Cichero, Elena, Silvana Alfei, Paola Altieri, et al.. (2023). Scouting Different Phosphodiesterase 4 Inhibitor Chemotypes in Silico To Guide the Design of Anti‐inflammatory/Antioxidant Agents. ChemMedChem. 18(9). e202300046–e202300046. 2 indexed citations
10.
Paes, Dean, Melissa Schepers, Ben Rombaut, et al.. (2023). Ablation of specific long PDE4D isoforms increases neurite elongation and conveys protection against amyloid-β pathology. Cellular and Molecular Life Sciences. 80(7). 178–178. 13 indexed citations
11.
Musumeci, Francesca, Annalisa Salis, Chiara Brullo, et al.. (2023). Virtual Screening Combined with Enzymatic Assays to Guide the Discovery of Novel SIRT2 Inhibitors. International Journal of Molecular Sciences. 24(11). 9363–9363. 6 indexed citations
12.
Brullo, Chiara, Marta S. Semrau, Silvana Alfei, et al.. (2021). Design, synthesis, biological evaluation and structural characterization of novel GEBR library PDE4D inhibitors. European Journal of Medicinal Chemistry. 223. 113638–113638. 11 indexed citations
13.
Signorello, Maria Grazia, et al.. (2021). New Series of Pyrazoles and Imidazo-Pyrazoles Targeting Different Cancer and Inflammation Pathways. Molecules. 26(19). 5735–5735. 7 indexed citations
14.
Brullo, Chiara, Silvana Alfei, Irena Maric, et al.. (2020). Discovery of New Antiproliferative Imidazopyrazole Acylhydrazones Able To Interact with Microtubule Systems. ChemMedChem. 15(11). 961–969. 7 indexed citations
15.
Brullo, Chiara, et al.. (2020). Pyrazolyl-Ureas as Interesting Scaffold in Medicinal Chemistry. Molecules. 25(15). 3457–3457. 23 indexed citations
16.
Meta, Elda, Chiara Brullo, Adama Sidibé, Beat A. Imhof, & Olga Bruno. (2017). Design, synthesis and biological evaluation of new pyrazolyl-ureas and imidazopyrazolecarboxamides able to interfere with MAPK and PI3K upstream signaling involved in the angiogenesis. European Journal of Medicinal Chemistry. 133. 24–35. 26 indexed citations
17.
Brullo, Chiara, Roberta Ricciarelli, Jos Prickaerts, et al.. (2016). New insights into selective PDE4D inhibitors: 3-(Cyclopentyloxy)-4-methoxybenzaldehyde O-(2-(2,6-dimethylmorpholino)-2-oxoethyl) oxime (GEBR-7b) structural development and promising activities to restore memory impairment. European Journal of Medicinal Chemistry. 124. 82–102. 35 indexed citations
18.
Tuccinardi, Tiziano, Alessandra Zizzari, Chiara Brullo, et al.. (2011). Substituted pyrazolo[3,4-b]pyridines as human A1 adenosine antagonists: Developments in understanding the receptor stereoselectivity. Organic & Biomolecular Chemistry. 9(12). 4448–4448. 15 indexed citations
19.
Bruno, Olga, Ernesto Fedele, Jos Prickaerts, et al.. (2011). GEBR-7b, a novel PDE4D selective inhibitor that improves memory in rodents at non-emetic doses. British Journal of Pharmacology. 164(8). 2054–2063. 120 indexed citations
20.
Schenone, Silvia, Chiara Brullo, Francesca Musumeci, & Maurizio Botta. (2010). Novel dual Src/Abl inhibitors for hematologic and solid malignancies. Expert Opinion on Investigational Drugs. 19(8). 931–945. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniela M. Zisterer Breakdown of academic impact, for papers by Joseph M. Salvino Breakdown of academic impact, for papers by Chuan Shih Breakdown of academic impact, for papers by Maryse Leost Breakdown of academic impact, for papers by Akira Asai Breakdown of academic impact, for papers by Armando Rossello Breakdown of academic impact, for papers by Hiroyuki Miyachi Breakdown of academic impact, for papers by Gyoonhee Han Breakdown of academic impact, for papers by Thelma S. Angeles Breakdown of academic impact, for papers by Daniel L. Flynn
Rankless by CCL
2026